Clinical Trial Update: The Objective of This Study is to Evaluate the Efficacy and Safety of Botulax® in Patients With Essential Blepharospasm. [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of Botulax® in patients with essential blepharospasm has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Blepharospasm

Drugs mentioned

• Botulax (botulinum toxin type A)

Snippet

Sponsor: Hugel | Conditions: Essential Blepharospasm | Phase 4 | Status: COMPLETED